Synovial sarcomas are high-grade soft tissue sarcomas of primitive mesenchymal origin which are defined by a pathognomonic t(X;18)(p11,q11) translocation, and which occur in pediatric and adult populations. Herein we report a case of a 33-year-old female with a history of nasopharyngeal carcinoma status post radiotherapy, presenting with a poorly differentiated synovial sarcoma of the nasal cavity arising in the radiation field. While the development of radiation-associated sarcoma is a known complication of radiotherapy, to date only 10 cases of synovial sarcoma have been reported to occur in previously irradiated tissues. Moreover, only 1 case of poorly differentiated synovial sarcoma involving the nasopharynx has been described.
DillonPMaurerHJenkinsJ, et al. A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group. J Pediatr Surg. 1992;27:241–245.
2.
McGroryJEPritchardDJArndtCANascimentoAGRemsteinEDRowlandCM. Nonrhabdomyosarcoma soft tissue sarcomas in children. The Mayo Clinic experience. Clin Orthop Relat Res. 2000:247–258.
3.
SultanIRodriguez-GalindoCSaabRYasirSCasanovaMFerrariA. Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients. Cancer. 2009;115:3537-3547.
4.
FisherC. Synovial sarcoma. Ann Diagn Pathol. 1998;2:401–421.
ThwayKFisherC. Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol. 2014;18:369–380.
8.
NakaNTakenakaSArakiN, et al. Synovial sarcoma is a stem cell malignancy. Stem Cells. 2010;28:1119–1131.
9.
GarciaCBShafferCMAlfaroMP, et al. Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2. Oncogene. 2012;31:2323–2334.
10.
van de RijnMBarrFGXiongQBSalhanyKEFrakerDLFisherC. Radiation-associated synovial sarcoma. Hum Pathol. 1997;28:1325–1328.
11.
BakriAShinagareABKrajewskiKM, et al. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012;199:W208–W215.
12.
Al-DarajiWLasotaJFossRMiettinenM. Synovial sarcoma involving the head: analysis of 36 cases with predilection to the parotid and temporal regions. Am J Surg Pathol. 2009;33:1494–1503.
13.
SusterSMoranCA. Primary synovial sarcomas of the mediastinum: a clinicopathologic, immunohistochemical, and ultrastructural study of 15 cases. Am J Surg Pathol. 2005;29:569–578.
14.
WitkinGBMiettinenMRosaiJ. A biphasic tumor of the mediastinum with features of synovial sarcoma. A report of four cases. Am J Surg Pathol. 1989;13:490–499.
15.
CummingsNMDesaiSThwayK, et al. Cystic primary pulmonary synovial sarcoma presenting as recurrent pneumothorax: report of 4 cases. Am J Surg Pathol. 2010;34:1176–1179.
16.
NicholsonAGRigbyMLincolnCMellerSFisherC. Synovial sarcoma of the heart. Histopathology. 1997;30:349–352.
17.
KatakuraHFukuseTShiraishiI, et al. Mediastinal synovial sarcoma. Thorac Cardiovasc Surg. 2009;57:183–185.
18.
FisherCFolpeALHashimotoHWeissSW. Intra-abdominal synovial sarcoma: a clinicopathological study. Histopathology. 2004;45:245–253.
19.
MakhloufHRAhrensWAgarwalB, et al. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. Am J Surg Pathol. 2008;32:275–281.
20.
AlshariefANFageehMAlabdulkarimY. Monophasic synovial sarcoma presenting as a primary ileal mass: a case report and review of the literature. J Med Case Rep. 2012;6:83.
21.
RomeoSRossiSAcosta MarínM, et al. Primary Synovial Sarcoma (SS) of the digestive system: a molecular and clinicopathological study of fifteen cases. Clin Sarcoma Res. 2015;5:7.
22.
SchoolmeesterJKChevilleJCFolpeAL. Synovial sarcoma of the kidney: a clinicopathologic, immunohistochemical, and molecular genetic study of 16 cases. Am J Surg Pathol. 2014;38:60–65.
23.
JunLKeSZhaomingWLinjieXXinruY. Primary synovial sarcoma of the prostate: report of 2 cases and literature review. Int J Surg Pathol. 2008;16:329–334.
24.
ScheithauerBWAmramiKKFolpeAL, et al. Synovial sarcoma of nerve. Hum Pathol. 2011;42:568–577.
XiaoGYPanBCTianXYLiYLiBLiZ. Synovial sarcoma in cerebellum: a case report and literature review. Brain Tumor Pathol. 2014;31:68–75.
27.
HorbinskiCCieplyKBejjaniGKMcFaddenK. Primary intracranial dural-based synovial sarcoma with an unusual SYT fluorescence in situ hybridization pattern. J Neurosurg. 2008;109:897–903.
28.
KeithJLBilbaoJCroulS, et al. Clinical Neuropathology practice guide 6-2013: morphology and an appropriate immunohistochemical screening panel aid in the identification of synovial sarcoma by neuropathologists. Clin Neuropathol. 2013;32:461–470.
29.
FliederDBMoranCA. Primary cutaneous synovial sarcoma: a case report. Am J Dermatopathol. 1998;20:509–512.
30.
ClarkJRocquesPJCrewAJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994;7:502–508.
31.
CrewAJClarkJFisherC, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J. 1995;14:2333–2340.
32.
dos SantosNRde BruijnDRvan KesselAG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer. 2001;30:1–14.
33.
FisherC. Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations. Virchows Arch. 2010;456:153–166.
34.
SkyttingBNilssonGBrodinB, et al. A novel fusion gene, SYT-SSX4, in synovial sarcoma. J Natl Cancer Inst. 1999;91:974–975.
35.
MiddeljansEWanXJansenPWSharmaVStunnenbergHGLogieC. SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes. PLoS One. 2012;7:e33834.
36.
TamakiSFukutaMSekiguchiK, et al. SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier. PLoS One. 2015;10:e0142991.
37.
McBrideMJPuliceJLBeirdHC, et al. The SS18-SSX Fusion Oncoprotein Hijacks BAF Complex Targeting and Function to Drive Synovial Sarcoma. Cancer Cell. 2018;33:1128–1141.e7.
38.
BaranovEMcBrideMJBellizziAM, et al. A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma. Am J Surg Pathol. 2020;44:922–933.
39.
BradyMSGaynorJJBrennanMF. Radiation-associated sarcoma of bone and soft tissue. Arch Surg. 1992;127:1379–1385.
40.
MarkRJBailetJWPoenJ, et al. Postirradiation sarcoma of the head and neck. Cancer. 1993;72:887–893.
41.
MarkRJPoenJTranLMFuYSSelchMTParkerRG. Postirradiation sarcomas. A single-institution study and review of the literature. Cancer. 1994;73:2653–2662.
42.
FisherC. Synovial sarcoma: ultrastructural and immunohistochemical features of epithelial differentiation in monophasic and biphasic tumors. Hum Pathol. 1986;17:996–1008.
43.
ThwayKFisherC. Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol. 2014;18:369–380.
44.
ShiWIndelicatoDJMorrisCGScarboroughMTGibbsCPZloteckiRA. Long-term treatment outcomes for patients with synovial sarcoma: a 40-year experience at the University of Florida. Am J Clin Oncol. 2013;36:83–88.
45.
EggerJFCoindreJMBenhattarJCouckePGuillouL. Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases. Mod Pathol. 2002;15:998–1004.
46.
MischlerNEChuprevichTTormeyDCRamirezGMackEA. Synovial sarcoma of the neck associated with previous head and neck radiation therapy. Arch Otolaryngol. 1978;104:482–483.
47.
DeraedtKDebiec-RychterMSciotR. Radiation-associated synovial sarcoma of the lung following radiotherapy for pulmonary metastasis of Wilms’ tumour. Histopathology. 2006;48:473–475.
48.
Mullah-AliARamsayJABourgeoisJM, et al. Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma. J Pediatr Hematol Oncol. 2008;30:553–557.
49.
KubouchiYTaniguchiYMatsuokaY, et al. Radiation-induced synovial sarcoma of the lung diagnosed by gene analysis after the surgical resection of chondrosarcoma arising from the scapula. Ann Thorac Cardiovasc Surg. 2013;19:144–147.
50.
VoraASchneiderAB. Synovial sarcoma of the lung in a patient who received radioactive iodine therapy for thyroid cancer. Thyroid. 2013;23:371–375.
51.
WojtowiczMGlinskiBMucha-MaleckaAWojton-DziewonskaDHebzdaP. Synovial sarcoma - secondary cancer induced by radiotherapy. Case report. Onkologia I Radioterapia. 2013;24:19–24.
52.
Herrera-GoepfertR. Postradiation Synovial Sarcoma of the Common Bile Duct: A Previously Unreported Anatomic Site. Int J Surg Pathol. 2018;26:469–474.
53.
FaridMNgeowJ. Sarcomas Associated With Genetic Cancer Predisposition Syndromes: A Review. Oncologist. 2016;21:1002–1013.
54.
EvansDGHowardEGiblinC, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A:327–332.
55.
EvansDGBaserMEMcGaughranJSharifSHowardEMoranA. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet. 2002;39:311–314.
56.
ParshadRPriceFMPirolloKFChangEHSanfordKK. Cytogenetic response to G2-phase X irradiation in relation to DNA repair and radiosensitivity in a cancer-prone family with Li-Fraumeni syndrome. Radiat Res. 1993;136:236–240.
57.
WongFLJrBoice JDAbramsonDH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997;278:1262–1267.
58.
HeymannSDelalogeSRahalA, et al. Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol. 2010;5:104.
